Edit |   |
---|---|
Antigenic Specificity | ERK1/2 (PairedT202/Y204), Non-phospho |
Clone | polyclonal |
Host Species | Rabbit |
Reactive Species | human, mouse, rat, chicken, dog |
Isotype | n/a |
Format | epitope affinity purified |
Size | 0.1 mg |
Concentration | Size: 100 ug/200 ul |
Applications | ELISA, Western Blot, Immunohistochemistry |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | This antibody recognizes ERK1/2 without the dual phosphorylation sites Thr202 and Tyr 204. It does not cross-react with Phosphospecific peptide. The extracellular signal-regulated kinases 1/2 (ERK1/2) are also known as MAPK (Mitogen-activated protein kinases) are a widely conserved family of serine/threonine protein kinases involved in many cellular programs such as cell proliferation, differentiation, motility, and death. The p44/42 MAPK (ERK1/2) signaling pathway can be activated in response to a diverse range of extracellular stimuli including mitogens, growth factors, and cytokines and is an important target in the diagnosis and treatment of cancer. The phosphorylation of MAPK at Thr202 and Tyr 204 are correlated to the progression and me |
Immunogen | Antigen Preparation: A synthetic peptide derived from epitope -LTEYV- without the dual phosphorylation sites Thr202 and Tyr204 of ERK1/2 protein from human, rat, mouse and dog origins. |
Other Names | n/a |
Gene, Accession # | [ERK1/2 (P44-MAPK) (PairedT202/Y204)] |
Catalog # | MBS462158 |
Price | $265 |
Order / More Info | ERK1/2 (PairedT202/Y204), Non-phospho Antibody from MYBIOSOURCE INC. |
Product Specific References | M. Klink, et al. Ovarian Cancer Cells Modulate Human Blood Neutrophils Response to Activation In Vitro. Clinical Immunology, 68 (3), 328-336. 2008. |